CSX Corporation
NASDAQ:CSXRailroads
-$0.06 today
- Market cap
- $94.62B
- Beta
- 1.22
- P/E (TTM)
- 27.8
- EPS (TTM)
- $1.64
- Dividend yield
- 1.19%
Volume 7.09M
Average 12.77M
CSX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
CSX CorporationNASDAQ: CSX
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures turns negative
Q3 FY2026 capital expenditures was -$593M, compared with $1.5B a year earlier. Trailing-twelve-month capital expenditures was -$2.39B. Over 3 fiscal years it compounded at +10.8% a year.
Context
- Capital expenditures amounted to 20.6% of revenue in FY2025, up 3.2 pp from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near -$593M or moves back toward the trailing-twelve-month quarterly average of -$597.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (2.9B) USD
- Year-over-year change
- -14.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.9B) | -14.7% |
| FY2024 | 2024-12-31 | (2.53B) | -12.1% |
| FY2023 | 2023-12-31 | (2.26B) | -5.8% |
| FY2022 | 2022-12-31 | (2.13B) | -19.1% |
| FY2021 | 2021-12-31 | (1.79B) | — |
Capital Expenditures vs competitors
How CSX compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +185.1% is the highest of 5, against a peer median of +9.2%.
- Capital expenditures amounts to 16.0% of revenue for CSX, versus a peer median of 15.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.83B USD | +3.2% | +1.6% | 14.5% | |
| LTM Jun 2026 | CA$3.44B CAD | +15.2% | +26.3% | 22.3% | |
| LTM Sep 2026 | CA$3.15B CAD | -6.7% | +9.9% | 17.2% | |
| LTM Sep 2026 | $2.39B USD | +185.1% | +10.8% | 16.0% | |
| LTM Sep 2026 | $68M USD | +103.2% | +4.2% | 0.5% | |
| Peer median (excluding CSX) | — | +9.2% | +7.1% | 15.9% | |
Competitors are the stored peer set for CSX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 3.78B | 4.17B | 3.67B | 3.47B | 2.89B |
| Depreciation & Amortization | 1.42B | 1.5B | 1.61B | 1.66B | 1.68B |
| Deferred Income Tax | 167M | 117M | 126M | 12M | 194M |
| Stock-Based Compensation | 0 | 74M | 0 | 40M | 0 |
| Change in Working Capital | 173M | 91M | 154M | 74M | (244M) |
| Accounts Receivables | (141M) | (101M) | (51M) | 82M | 88M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 128M | 140M | 83M | (5M) | 40M |
| Other Working Capital | 186M | 52M | 122M | (3M) | (372M) |
| Other Non-Cash Items | (442M) | (331M) | (41M) | (7M) | 94M |
| Operating Cash Flow | 5.1B | 5.62B | 5.51B | 5.25B | 4.61B |
| Capital Expenditures | (1.79B) | (2.13B) | (2.26B) | (2.53B) | (2.9B) |
| Acquisitions (Net) | (541M) | (227M) | (31M) | (70M) | (16M) |
| Purchases of Investments | (75M) | (59M) | (104M) | (66M) | 0 |
| Sales of Investments | 5M | 9M | 153M | 91M | 80M |
| Other Investing Activities | 525M | 279M | 12M | (31M) | (13M) |
| Investing Cash Flow | (1.88B) | (2.13B) | (2.23B) | (2.61B) | (2.85B) |
| Debt Repayment | (426M) | 1.81B | 447M | (8M) | 287M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.89B) | (4.73B) | (3.48B) | (2.24B) | (1.4B) |
| Dividends Paid | (839M) | (852M) | (882M) | (930M) | (972M) |
| Other Financing Activities | 39M | 0 | 50M | 113M | 56M |
| Financing Cash Flow | (4.11B) | (3.77B) | (3.87B) | (3.06B) | (2.03B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (890M) | (281M) | (580M) | (420M) | (263M) |
| Free Cash Flow | 3.31B | 3.49B | 3.26B | 2.72B | 1.71B |
CSX Corporation
NASDAQ:CSX
Intrinsic Alpha fair value
Locked
Current Price
$51.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.